Q1. What is a systematic internaliser?



Similar documents
MiFID II Trading Venues And High Frequency Trading

MiFID 2: markets. Summary. Key business impacts. Key business impacts. Trading venues. Trading and clearing requirements. Algorithmic trading

MiFID II: The new market structure paradigm

CESR Technical Advice to the European Commission in the Context of the MiFID Review Equity Markets

Flash News. European Parliament adopts MiFID II. 1. Background. 2. MiFID II for banks, investment firms and asset managers

MiFID 2 for asset managers

Markets in Financial Instruments Directive II Implementation

Revision of the Markets in Financial Instruments Directive (MiFID II) Fact Sheet

Summary. Key business impacts. Key business impacts. Trading venues. Product intervention commodity derivatives

MiFID II/MiFIR series

Table of content. MiFID II: getting ready for implementation

MiFID/MiFIR: The OTF and SI regime for OTC derivatives

Eighth Annual Markets Infrastructure Group Seminar: How will MiFID change the way we trade? Imogen Garner Partner 8 July 2015

Reply form for the ESMA MiFID II/MiFIR Discussion Paper. Template for comments for the ESMA MiFID II/MiFIR Discussion Paper

MiFID II / MiFIR: Your Survival Guide Market Structures Tying it All Together

OTC derivatives reforming EU market structures. Ash Saluja, Partner CMS Cameron McKenna LLP

EBF response to ESMA consultation on the exemption for market making activities and primary market operations under Regulation (EU) 236/2012

InfoNet MiFID II/R Seminar Series

International Capital Market Association ICMA

AIMA BRIEFING NOTE. The interplay between European and US derivatives trading rules. July 2015 (version 2)

MiFID/MiFIR REPORTING FIELD COMPARISON

Evolutionary Change. The future of electronic trading in European cash bonds. April 2016

Interest Representative Register ID number: August By to: Dear Sir/Madam

Market Analysis The Nature and Scale of OTC Equity Trading in Europe April 2011

2012 Fidessa group plc

MiFID II Key aspects. I. Introduction

EUROPEAN COMMISSION Directorate General Internal Market and Services. FINANCIAL SERVICES POLICY AND FINANCIAL MARKETS Securities markets

COMMISSION STAFF WORKING PAPER EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT. Accompanying the document. Proposal for a

FX & MIFID ECB FX Contact Group

ORDER TRANSMISSION AND EXECUTION POLICY FOR PROFESSIONAL CLIENTS

Electronic trading under MiFID-II

MiFID - what is it, and what does it mean?

Reply form for the ESMA MiFID II/MiFIR Consultation Paper. Template for comments

Transaction reporting

How To Write A New Law In The Uk

Recognised Investment Exchanges. Chapter 2. Recognition requirements

Top Ten Things every Fund Manager should know about MiFID2

Transaction Reporting - What is Changing Under MiFID II

How To Understand The New Financial Regulations In European Law

MiFID II: Impact on company financing in Belgium

Pre-trade and execution services under MiFID LEADING SOLUTIONS FOR A PAN-EUROPEAN MARKET

Report on Trading of OTC Derivatives

A REGULATORY UPDATE ON CMU, MIFID II AND ITS EFFECT ON EUROPEAN COMPANIES

Final Report Draft Regulatory and Implementing Technical Standards MiFID II/MiFIR

Nordea Execution Policy

ICAP Execution Policy

Green Paper of the European Commission on Long-Term Financing of the Economy

Knight Capital Europe Limited

MARKETS IN FINANCIAL INSTRUMENTS DIRECTIVE II. Implementing the Legislation

MiFID II/MiFIR series

Order Execution Policy

Best execution under MIFID

CREDITEX BROKERAGE LLP BEST EXECUTION POLICY

Summary of Scotiabank London Best Execution Policy

Best Execution Policy

INVESTMENT MANAGEMENT ASSOCIATION PENSION FUND DISCLOSURE CODE

BEST EXECUTION POLICY - FINANCIAL INSTRUMENTS

DELEGATED REGULATION (EU)

EUROPEAN SECURITIES AND MARKETS AUTHORITY (ESMA) CONSULTATION PAPER

Preventing market abuse: Can market surveillance really improve amidst fragmentation and low-cost competition?

Pictet Asset Management: Summary of Best Execution Policy

Financial Services Authority Transaction Reporting Forum. April 2012

FINAL, SENT 13:45 CET, 25/09/2013 via

MiFID II: Microstructural Issues

30 January Via Electronic Submission. Fair and Effective Markets Review c/o Bank of England Threadneedle Street London, EC2R 8AH

EXANE GROUP EXECUTION POLICY

Sea of Change Regulatory reforms charting a new course. Regulation of OTC derivatives markets. A comparison of EU and US initiatives.

Fixed Income TCA. TCA and its use in fixed income reducing cost, bringing transparency and moving towards electronic trading in fixed income

F R E Q U E N T L Y A S K E D Q U E S T I O N S A B O U T E U R O P E A N S E C U R I T I E S L E G I S L A T I ON

PVM Execution Policy. A tullett prebon company. PVM Oil Associates Ltd. PVM Oil Futures Ltd. London

A guide to London Stock Exchange trading services for equity securities

Discussion Paper 06/3. Financial Services Authority. Implementing MiFID s best execution requirements

CESR Consultation on guidance to report transactions on OTC derivative instruments [CESR/09-768]

ESMA MiFID II / MiFIR Consultation and Discussion Papers General Comments on Market Structure Issues

Buy-ins, how they work, and the challenge of CSDR An ICMA briefing note July 2015 (updated) Introduction. How this paper is organized

ICMA: Response to ESMA CSD Regulation Level 2 Consultation Papers. February 19 th 2015

A Guide to MiFID Investment Services in Ireland

Transcription:

MiFID II/R: Systematic Internalisers A Q&A for bond markets July 2015 Q1. What is a systematic internaliser? A. A systematic internaliser (SI), under the EU MiFID regime, is an investment firm that deals on its own account by executing client orders outside a trading venue. MiFID I MiFID I, in 2007, introduced the definition for European equity markets, defining an SI as an investment firm which, on an organised, frequent and systematic basis, deals on own account by executing client orders outside a regulated market or an MTF. The core requirement for SIs is to publish firm quotes in shares admitted to trading on a regulated market that are classified as 'liquid' under MiFID when dealing in sizes up to standard market size. Under MiFID I, there is no specific definition of frequent or systematic, and investment firms can elect to become SIs at their own discretion. Following the introduction of the regime, very few firms became SIs. MiFID II/R MiFID II/R extends the SI regime to other financial instruments, including bonds, and broadens the definition to an investment firm which, on an organised, frequent and systematic, and substantial basis, deals on its own account by executing client orders outside a RM, MTF, or OTF. Furthermore, the regulation specifies quantifiable definitions for frequent and systematic, and substantial, based on trading volumes (see below). Q2. Why does MiFID II/R introduce the SI regime for bonds? A. The rationale for the SI regime is to move dark, off-venue trading, on to lit venues by creating a level playing field and greater price transparency between OTC and venues. The key requirement of an SI, compared to a non-si, is that it is subject to similar pre-trade transparency obligations as a RM, MTF, or OTF, as this is expected to aid price formation for investors. Q3. How do I become a systematic internaliser? A. MiFID II/R level 2 will set out clearly defined thresholds for becoming an SI, based on trading volumes in respect of frequent and systematic and substantial. 1 1 See: ESMA s final Technical Advice to the Commission on MiFID II and MiFIR (December 2014) 1

Proposed trading thresholds for SIs: frequent and systematic The frequent and systematic basis will be measured by the number of OTC (off venue) trades in the financial instrument carried out by the investment firm executing client orders on its own account. For liquid bonds, this is where the number of trades executed off venue during the last six months is equal to or larger than 2-3% of the total number of transactions in the relevant financial instruments in the EU executed on any venue or OTC during the same period. At a minimum, the firm shall deal on its own account in the instrument once a week. For illiquid bonds, this is where the firm has dealt on its own account OTC in the financial instrument on average once a week during the last six months. Proposed trading thresholds for SIs: substantial The substantial basis will be measured either by the size of the firm s OTC trading on own account in relation to the total trading of the firm in a specific instrument, or by the size of the firm s OTC trading on own account compared with the total trading in the EU in a specific financial instrument. The firm internalises on a substantial basis if the size of OTC trading on own account during the last six months is equal to or larger than: 25% of the total nominal amount traded in that financial instrument executed by the investment firm on its own account or on behalf of clients, and carried out on any trading venue or OTC; or 0.5-1.5% of the total nominal amount traded in that financial instrument executed in the EU and carried out on any EU trading venue or OTC. Firms will be required, on a quarterly basis, to assess whether they meet the criteria for both frequent and systematic and substantial, and should they qualify they will register themselves as an SI with the relevant NCA, which in turn will notify ESMA (who will maintain a list of all SIs in the EU). Q4. Is being an SI optional? A. If an investment firm does not meet the quantitative criteria it may still be able to opt-in to become classified as an SI, so long as it complies with all the applicable requirements. However, there is no option to opt-out. If a firm wishes not to be an SI, then it must fail either the frequent and systematic or the substantial quarterly tests. 2

Q5. Do I become an SI on a specific instrument basis, or by market type or asset class? A. Firms become SIs for bonds (either through meeting the trading threshold criteria or by opting-in) on an instrument-by-instrument basis. Q6. How often are the SI criteria re-assessed? A. Investment firms are required to assess whether they meet both the frequent and systematic and substantial criteria on a quarterly basis, based on data from the last six months. These assessments are to be performed on the first working day of January, April, July, and October. For new (non-equity) instruments, the assessments are only to be considered once the data covers a minimum period of six weeks. Q7. What are the reporting requirements of an SI? A. SIs are subject to comparable pre-trade reporting requirements as RMs, MTFs, and OTFs. They are also subject to the same reporting waivers for illiquid markets, orders that are large in scale (LIS), orders that are equal to or larger than the relevant size specific to the instrument (SSTI), and orders held in a management system. For OTC quotes made by an investment firm in their capacity as an SI, the firm will be identifiable; whereas quotes provided on a venue will be averaged with those of all other quoting firms, and anonymized. SIs are also subject to the same post-trade transparency requirements and waivers as RMs, MTFs, OTFs, and other investment firms. Q8. What discretion do I have in my quoting and trading as an SI? A. SIs for bonds are required to provide firm quotes to clients on request (in standard market size) for liquid bonds. However, SIs are able to limit the number of transactions a client may enter into, and the clients to whom the quotes are provided, so long as its commercial policy is set in a non-discriminatory way (e.g. a policy of one transaction per quote ). Thus, SIs are able to manage their trading activity and the costs and risks associated with this. 3

Q9. Can I be an SI and operate an OTF? A. No. MiFID II/R does not allow the operation of an OTF and systematic internalization within the same legal entity. Q10. Are there any benefits to being an SI? A. There are no obvious benefits from a market-making perspective. It could be possible that some investors, as part of their best execution policy, may require quotes from SIs for specific instruments when trading OTC. Alternatively, whether a bond has a certain number of registered SIs could be a component of an investor s internal liquidity scoring. However, given that being an SI is no guarantee of either competitive pricing or liquidity, these scenarios seem unlikely, and investors are unlikely to differentiate between SIs and non-sis when requesting quotes. Q11. Are there any advantages to not being an SI? A. Investment firms who do not qualify as SIs are not subject to the same pre-trade transparency requirements as SIs. Furthermore, where non-sis qualify for the post-trade transparency exemption, they only have to publish trade data on a quarterly basis, not monthly. Q12. When will the SI regime come into force? A. MiFID II/R is expected to come into force in January 2017. Q13. Is the SI regime likely to have any positive outcomes for bond market pricing or liquidity? A. The general view is that any impact will be limited. The criteria for becoming an SI are sufficiently high enough for many investment firms to avoid becoming an SI, and so it is likely that a significant proportion of bond trading will remain OTC, or exempt from pre-trade transparency obligations. Also, the pricing and trading discretion that SIs will need to retain as part of their commercial policy will mean that any pre-trade pricing transparency is not necessarily meaningful from a price formation perspective. Prepared by Andy Hill 4

ICMA Secondary Markets contacts Elizabeth Callaghan liz.callaghan@icmagroup.org +44(0)20 7213 0313 Alexander Westphal alexander.westphal@icmagroup.org +44(0)20 7213 0333 Andy Hill andy.hill@icmagroup.org +44(0)20 7213 0335 This paper is provided for information purposes only and should not be relied upon as legal, financial, or other professional advice. While the information contained herein is taken from sources believed to be reliable, ICMA does not represent or warrant that it is accurate or complete and neither ICMA nor its employees shall have any liability arising from or relating to the use of this publication or its contents. International Capital Market Association (ICMA), Zurich, 2015. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means without permission from ICMA. 5